Current Employment Position(s)

Partner

Lawyer Overview

Steve Fluckiger has been the principal lawyer on more than 150 rounds of private equity, venture-backed, and angel financings aggregating over $4 billion, representing both issuers and institutional, as well as individual investors. For the past several years, Steve has served as principal outside counsel to Maverick Capital on private investment, merger and acquisition, restructuring, and private portfolio company governance matters.

Steve also regularly advises emerging growth and other private and public software, biotech, outsourcing, renewable energy, nanotech, and manufacturing companies in connection with their merger and acquisition, financing, intellectual property licensing, joint venture, distribution and strategic alliance, executive compensation, and corporate governance matters.

Steve serves on the advisory board of the Cecil H. and Ida Green Center for Systems Biology Science at University of Texas Dallas and University of Texas Southwestern Medical Center and the advisory board of the Institute for Innovation and Entrepreneurship at University of Texas Dallas. He is past chair of the advisory board of the Institute of Biomedical Sciences and Technology, a multidisciplinary biomedical research consortium, and served on the advisory board of the North Texas Life Sciences Society. He also chaired the Dallas Regional Chamber's CEO Lifesciences Roundtable and the Dallas/Fort Worth chapter of the J. Reuben Clark Law Society. Steve is a member of BioDFW, the Texas Healthcare and Bioscience Institute, and the Life Sciences and Sustainable Technologies Committees of the Technology Business Council of the Dallas Regional Chamber.

Areas of Practice

• Intellectual Property
• Licensing & Technology Transactions
• Mergers & Acquisitions
• M&A
• Private Equity
• Buyouts
• Fund Formation
• Venture Capital - Investor
• Venture Capital - Issuer
• Life Sciences

Representative Cases

• Acquisition by John Henry Holdings
• Acquisition of business
• Acquisition of business
• Acquisition of company
• Acquisition of Health Care Information Technology Business
• Acquisition of MedGrup
• Acquisition of software company
• Chapter 11 reorganization
• Common and Preferred Stock and Related Debt Financing
• Common Stock Offering
• Company Formation, Financing and Technology Acquisition
• Convertible Preferred Stock Offering
• Corporate formation and technology licensing
• Corporate reorganization
• Distribution and Marketing Agreement
• Equity Offering
• Exchange Offer , (2009)
• Formation of venture capital partnership
• Intellectual property license
• Issuance of Convertible Preferred Stock by Disc Dynamics, Inc.
• Issuance of Preferred Stock by Fresh Direct Holdings, Inc.
• Issuance of Series C Convertible Preferred Stock by Xoft, Inc.
• Issuance of Shares
• Issuance of Shares by Affinity Media, Inc.
• Issuance of Shares by Ambrx, Inc.
• Issuance of Shares by Ambrx, Inc.
• Issuance of Shares by Ambrx, Inc.
• Issuance of Shares by Cardiovascular Systems, Inc.
• Issuance of Shares by CognitiveDATA, Inc.
• Issuance of Shares by CoreValve, Inc.
• Issuance of Shares by Microbia, Inc.
• Issuance of Shares by MitralSolutions, Inc.
• Issuance of Shares by Mixed Signals, Inc.
• Issuance of Shares by Nodality, Inc.
• Issuance of Shares by Pacific Biosciences , (2009)
• Issuance of Shares by Perlegen Sciences, Inc.
• Issuance of Shares by Perputo, Inc.
• Issuance of Shares by Realtime Worlds, Inc.
• Issuance of Shares by Xoft, Inc.
• Issuance of Shares by Youku.com , (2009)
• Merger with Critical Path
• Outsourcing
• Outsourcing joint venture
• Preferred stock offering
• Preferred stock offering
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Equity Financing
• Private Placement
• Private Placement by Corcept Therapeutics
• Private Placement by Metabasis Therapeutics, Inc.
• Private Placement by Perlegen Sciences, Inc.
• Public offering of common stock
• Registered Direct Offering , (2009)
• Research and Development Joint Ventures
• Sale of business
• Sale of business
• Sale of division
• Sale of financial institution
• Sale of financial institution
• Self-tender offer
• Software Development Joint Venture
• Special Board Committee Representation
• Spin-off of non-core businesses followed by IPO
• Stock-for-Stock Acquisition

West Practice Categories

Banking & Finance Law, Business & Commercial Law, Business Organizations, Business Successions, Closely Held Businesses, Copyrights, Corporate Governance, Directors' & Officers' Liability, Dissolution, Formation & Business Planning, Franchising, Intellectual Property Law, International Intellectual Property, Joint Ventures, Lending & Secured Transactions, Limited Liability Companies, Mergers, Acquisitions & Divestitures, Non-profit & Tax-exempt Organizations, Partnerships, Patents, Reorganizations, Shareholders' Rights, Technology Licensing, Trade Associations, Trade Dress, Trade Secrets, Trademarks, Venture Capital

Bar Admissions

• Texas

Education

• Brigham Young University

Published Works

• Economic Development and Commercialization Subcommittee, Cancer Prevention and Research Institute of Texas, Comments on Intellectual Property Standards and Protection of Confidential Information, 2009
• Current Trends in Life Science Investing, Jones Day Technology Transactions Mid-Year 2003 Newsletter, 2003
• Biotech Business is Building in Dallas, Dallas-Fort Worth TechBiz, 2001
• Over-the-Counter Debt Offerings Raise Capital, Outlook of the Federal Home Loan Bank System, 1998
• The Mexican Banking Crisis: Remedies and Opportunities, Consumer Finance Law Quarter Report, 1998
• New Risk-Based Capital Measures Mark Shift Toward Reliance on Self-Assessment, Bank Accounting & Finance, 1995
• How S&L's Can Use Over-the-Counter Offerings, American Banker, 1987
• The Changing Relationship of the Judiciary to the Policy and Administrative Processes of Governments, B.Y.U. Law Review, 1985

Address

2727 North Harwood Street
Dallas, TX 75201-1515

Phones

1.214.969.3702 (Business Phone)

Faxes

1.214.969.5100 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com